Reporting person on SEC Form 4

Gregory R Friberg

Gregory R Friberg is EVP, Chief R&D Officer at BioMarin Pharmaceutical. OQRO lists 6 transactions filed with the SEC under this name, the latest on Oct 1, 2026, each linked to the official Form 4.

EVP, Chief R&D Officer

Disclosures on record

6

Companies involved

1

Disclosure history

BioMarin PharmaceuticalBMRN
6 disclosures · Feb 2026 – Oct 2026 · 2 sold
- Sep 30, 20264,086disclosed Oct 1
  Details Official record
- May 7, 2026Sold~$177Kdisclosed May 11
  Details Official record

Mar 16, 202619Kdisclosed Mar 18

Details Official record

Mar 16, 202646Kdisclosed Mar 18

Details Official record

Mar 17, 20261,629disclosed Mar 18

Details Official record

Feb 26, 2026Sold~$382Kdisclosed Feb 27

Details Official record

All activity in BioMarin Pharmaceutical